157 related articles for article (PubMed ID: 15345766)
1. Comparative prevalence of psychotropic medications among youths enrolled in the SCHIP and privately insured youths.
Safer DJ; Zito JM; Gardner JF
Psychiatr Serv; 2004 Sep; 55(9):1049-51. PubMed ID: 15345766
[TBL] [Abstract][Full Text] [Related]
2. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
Martin A; Leslie D
Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
[TBL] [Abstract][Full Text] [Related]
4. Multiple psychotropic medication use for youths: a two-state comparison.
dosReis S; Zito JM; Safer DJ; Gardner JF; Puccia KB; Owens PL
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):68-77. PubMed ID: 15741788
[TBL] [Abstract][Full Text] [Related]
5. Children with special health care needs enrolled in the State Children's Health Insurance Program (SCHIP): patient characteristics and health care needs.
Szilagyi PG; Shenkman E; Brach C; LaClair BJ; Swigonski N; Dick A; Shone LP; Schaffer VA; Col JF; Eckert G; Klein JD; Lewit EM
Pediatrics; 2003 Dec; 112(6 Pt 2):e508. PubMed ID: 14654673
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.
Zito JM; Burcu M; Ibe A; Safer DJ; Magder LS
Psychiatr Serv; 2013 Mar; 64(3):223-9. PubMed ID: 23242390
[TBL] [Abstract][Full Text] [Related]
7. The evolution of the State Children's Health Insurance Program (SCHIP) in New York: changing program features and enrollee characteristics.
Dick AW; Klein JD; Shone LP; Zwanziger J; Yu H; Szilagyi PG
Pediatrics; 2003 Dec; 112(6 Pt 2):e542. PubMed ID: 14654676
[TBL] [Abstract][Full Text] [Related]
8. Impact of a private health insurance mandate on public sector autism service use in Pennsylvania.
Stein BD; Sorbero MJ; Goswami U; Schuster J; Leslie DL
J Am Acad Child Adolesc Psychiatry; 2012 Aug; 51(8):771-9. PubMed ID: 22840548
[TBL] [Abstract][Full Text] [Related]
9. Mental health services for youths in foster care and disabled youths.
dosReis S; Zito JM; Safer DJ; Soeken KL
Am J Public Health; 2001 Jul; 91(7):1094-9. PubMed ID: 11441737
[TBL] [Abstract][Full Text] [Related]
10. Trends in psychotropic medication costs for children and adolescents, 1997-2000.
Martin A; Leslie D
Arch Pediatr Adolesc Med; 2003 Oct; 157(10):997-1004. PubMed ID: 14557161
[TBL] [Abstract][Full Text] [Related]
11. Multimodal treatment for ADHD among youths in three Medicaid subgroups: disabled, foster care, and low income.
dosReis S; Owens PL; Puccia KB; Leaf PJ
Psychiatr Serv; 2004 Sep; 55(9):1041-8. PubMed ID: 15345765
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsant treatment for psychiatric and seizure indications among youths.
Zito JM; Safer DJ; Gardner JF; Soeken K; Ryu J
Psychiatr Serv; 2006 May; 57(5):681-5. PubMed ID: 16675763
[TBL] [Abstract][Full Text] [Related]
13. Treatment use and costs among privately insured youths with diagnoses of bipolar disorder.
Dusetzina SB; Farley JF; Weinberger M; Gaynes BN; Sleath B; Hansen RA
Psychiatr Serv; 2012 Oct; 63(10):1019-25. PubMed ID: 22855210
[TBL] [Abstract][Full Text] [Related]
14. Trends in the use of psychotropic medications among adolescents, 1994 to 2001.
Thomas CP; Conrad P; Casler R; Goodman E
Psychiatr Serv; 2006 Jan; 57(1):63-9. PubMed ID: 16399964
[TBL] [Abstract][Full Text] [Related]
15. Mental health treatment received by youths in the year before and after a new diagnosis of bipolar disorder.
Olfson M; Crystal S; Gerhard T; Huang CS; Carlson GA
Psychiatr Serv; 2009 Aug; 60(8):1098-106. PubMed ID: 19648198
[TBL] [Abstract][Full Text] [Related]
16. Inpatient treatment of comorbid psychiatric and substance abuse disorders: comparison of public sector and privately insured populations.
Leslie DL; Rosenheck R
Adm Policy Ment Health; 1999 Mar; 26(4):253-68. PubMed ID: 10431398
[TBL] [Abstract][Full Text] [Related]
17. Substitution of SCHIP for private coverage: results from a 2002 evaluation in ten states.
Sommers A; Zuckerman S; Dubay L; Kenney G
Health Aff (Millwood); 2007; 26(2):529-37. PubMed ID: 17339683
[TBL] [Abstract][Full Text] [Related]
18. Use of psychotropic medications by youths with psychiatric diagnoses in the U.S. mental health system.
Warner LA; Pottick KJ; Mukherjee A
Psychiatr Serv; 2004 Mar; 55(3):309-11. PubMed ID: 15001733
[TBL] [Abstract][Full Text] [Related]
19. Mental health policy and psychotropic drugs.
Frank RG; Conti RM; Goldman HH
Milbank Q; 2005; 83(2):271-98. PubMed ID: 15960772
[TBL] [Abstract][Full Text] [Related]
20. Psychotropic medication use among Kansas Medicaid youths with disabilities.
Shireman TI; Reichard A; Rigler SK
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):107-15. PubMed ID: 15741792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
